Literature DB >> 2197128

A review of current approaches to in-office management of tooth hypersensitivity.

H O Trowbridge1, D R Silver.   

Abstract

In-office treatment of dentinal hypersensitivity should be capable of providing the patient with immediate and lasting relief of pain. Regardless of the type of treatment employed, 20 to 40 per cent of hypersensitive teeth usually improve over a period of 4 to 8 weeks. Partial obturation of open tubules is the most widely practiced treatment, with other forms of therapy being recommended as a backup for patients in whom this approach fails. Obturation can be achieved with topical application of agents that form insoluble precipitates within the orifices of the tubules. Burnishing the exposed root surface produces a smear layer, which in itself can significantly reduce dentin permeability. At times, the use of a restorative resin or dentin bonding agent can be successful in reducing sensitivity when other forms of therapy have failed. Proper patient management should stress dietary counseling when dietary acids are an important etiologic factor. The importance of proper tooth brushing and plaque control must be stressed. At the present time, the use of oxalates for the obturation of tubules shows promise as a future in-office clinical agent; however, further clinical studies are required to evaluate and compare their efficacy with other currently effective methods and agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197128

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  9 in total

1.  Effect of Arginine and nano-hydroxyapatite application on the hypersensitivity and color change of bleached enamel: A randomized controlled clinical trial.

Authors:  Lamiaa M Moharam; Sherif Khadr; Ahmed Abdou; Shaymaa M Nagi
Journal:  J Clin Exp Dent       Date:  2022-06-01

2.  Treatments for hypersensitive noncarious cervical lesions: a Practitioners Engaged in Applied Research and Learning (PEARL) Network randomized clinical effectiveness study.

Authors:  Analia Veitz-Keenan; Julie Ann Barna; Brad Strober; Abigail G Matthews; Damon Collie; Donald Vena; Frederick A Curro; Van P Thompson
Journal:  J Am Dent Assoc       Date:  2013-05       Impact factor: 3.634

3.  Prevalence of dentinal hypersensitivity and study of associated factors: a cross-sectional study based on the general dental population of Davangere, Karnataka, India.

Authors:  Ryana Kour Haneet; Laxman Kharidi Vandana
Journal:  Int Dent J       Date:  2015-11-19       Impact factor: 2.607

4.  Evaluation of Dentifrice Containing Nano-hydroxyapatite for Dentinal Hypersensitivity: A Randomized Controlled Trial.

Authors:  Nithin Manchery Gopinath; Joseph John; N Nagappan; S Prabhu; E Senthil Kumar
Journal:  J Int Oral Health       Date:  2015-08

5.  Comparative evaluation of use of a diode laser and electrode application with and without two dentinal tubule occluding agents in the management of dentinal hypersensitivity - A clinical study.

Authors:  Chitra Laxmikant Patil; Dilip Ganpat Pol; Rajesh Prabhakar Gaikwad
Journal:  J Indian Soc Periodontol       Date:  2020-11-14

6.  Efficacy of an occluding toothpaste on dentinal hypersensitivity over 14 days.

Authors:  Jonathan E Creeth; Chhaju Goyal; Jimmy Qaqish; Robert Maclure; Jonathan S Holt
Journal:  BDJ Open       Date:  2021-07-13

7.  Evaluation of the clinical efficacy of potassium nitrate desensitizing mouthwash and a toothpaste in the treatment of dentinal hypersensitivity.

Authors:  Sunita Sharma; Neetha J Shetty; Ashita Uppoor
Journal:  J Clin Exp Dent       Date:  2012-02-01

8.  Effects of a mouthwash containing potassium nitrate, sodium fluoride, and cetylpyridinium chloride on dentin hypersensitivity: a randomized, double-blind, placebo-controlled study.

Authors:  Ji-Youn Hong; Hyun-Chang Lim; Yeek Herr
Journal:  J Periodontal Implant Sci       Date:  2016-02-15       Impact factor: 2.614

9.  Dentin abrasivity of various desensitizing toothpastes.

Authors:  W H Arnold; Ch Gröger; M Bizhang; E A Naumova
Journal:  Head Face Med       Date:  2016-04-02       Impact factor: 2.151

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.